Retained Target definition

Retained Target means any target that Merck and NGM have mutually agreed in writing will not be researched in the course of the Full Research Program Term.
Sample 1Sample 2
Retained Target has the meaning set forth in Section 3.1.7.
Sample 1Sample 2

Examples of Retained Target in a sentence

  • Isis will promptly notify Alnylam when such ability to license Alnylam is obtained, and effective upon delivery of such notice to Alnylam, the applicable RNA Target will automatically no longer be an Isis Retained Target, and the Parties will update Schedule 1-69 accordingly as promptly as feasible.

  • The Retained Target Shares will represent 9.9% of the shares of Target Common Stock issued and outstanding immediately prior to the Effective Time.

  • Each Retained Target Founder will have voting rights with respect to the Escrow Shares deposited in the Escrow with respect to such Retained Target Founder so long as such Escrow Shares are held in the Escrow, and Acquirer shall take all reasonable steps necessary to allow the exercise of such rights.

  • If at any time ending on the third anniversary of the Closing Date Xxxxxx and Xxxxx Xxxxx (the "Clarks") desire to sell all or a portion (but not less than one-half) of the Retained Target Shares held by them as of the Closing to Merchant (the "Put Shares"), they shall provide Merchant with written notice of their election to require Merchant to purchase such shares (the "Put Election Notice").

  • The costs and expenses of enforcing this right of indemnification shall be paid by Acquirer and the Retained Target Founders, provided, however, that the Acquirer and the Retained Target Founders shall not pay such costs and expenses to the extent that the Escrow Agent is judicially determined to have been negligent or acted with willfull misconduct.

  • As the Sponsor of this clinical investigation, Biosense Webster has the overall responsibility for the conduct of the clinical investigation, including assurance that the clinical investigation meets the international regulatory requirements and any national regulations, as appropriate.

  • The Escrow Agent may resign giving at least thirty (30) days' written notice to the other parties; PROVIDED, HOWEVER that no such resignation shall become effective until the appointment of a successor Escrow Agent which shall be accomplished as follows: Acquirer and the Retained Target Founders shall use their best efforts to agree on a successor Escrow Agent within thirty (30) days after receiving such notice.

  • Overall Student Outcome Actual Actual Actual Actual 2010-11 2011-12 2012-13 2013-14 Sector 2013-14 Target Actual 2014-15 2014-15 Sector 2014-15 Revised Retained Target Target 2015-16 2016-17 FE Full Time 61.6% 62.9% 64.7% 65% 65.8% 66% 59.8% 64% 66% 68% HE Full Time 62.5% 65.4% 66% 68.9% 71.1% 70% 67.1% 71.3% 70% 73% Part Time success rates The College has worked to address a Regional Outcome and National target to reduce the percentage of non-assessed courses.

  • During the Term, prior to marketing or otherwise offering for sale, or soliciting any offer to buy, any of the properties described on Schedule E attached hereto or any right, title or interest therein (the “Retained Target Properties”), B&R shall offer to sell the Retained Target Properties to MDA (the “Right of First Offer”) by written notice to MDA containing the Basic Terms (as hereinafter defined) of such proposed sale (the “Offer Notice”).

  • The Escrow Agent shall forward to Retained Target Founders all voting materials and proxies received by the Escrow Agent.

Related to Retained Target

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • Acquisition Target means any Person becoming a Subsidiary of the Company after the date hereof; any Person that is merged into or consolidated with the Company or any Subsidiary of the Company after the date hereof; or any Person with respect to which all or a substantial part of that Person’s assets are acquired by the Company or any Subsidiary of the Company after the date hereof.

  • KPI Target means the acceptable performance level for a KPI as set out in relation to each KPI;

  • Sanctioned Target means any target of Sanctions, including (i) persons on any list of targets identified or designated pursuant to any Sanctions, (ii) persons, countries, or territories that are the target of any territorial or country-based Sanctions program, (iii) persons that are a target of Sanctions due to their ownership or control by any Sanctioned Target(s), or (iv) persons otherwise a target of Sanctions, including vessels and aircraft, that are designated under any Sanctions program.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • continuing candidate means any candidate not deemed to be elected, and not excluded,

  • Product Candidate means each biological and drug candidate, compound or other device or product being developed, labeled, manufactured, marketed, sold and/or distributed by the Company or a Company Subsidiary, or regarding which the Company or a Company has rights, and including any such biological and drug candidate, compound or product that has received Marketing Approval.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Independent candidate means any candidate who claims not to be affiliated with a political party, and whose name has been certified on the office-type ballot at a general or special election through the filing of a statement of candidacy and nominating petition, as prescribed in section 3513.257 of the Revised Code.

  • Pedestrian Target means a soft target that represents a pedestrian

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Valid write-in candidate means a candidate who has qualified as a write-in

  • Alternative nicotine product means any noncombustible product containing nicotine that is not made of tobacco and is intended for human consumption, whether chewed, absorbed, dissolved, or ingested by any other means. "Alternative nicotine product" does not include any nicotine vapor product or any product regulated as a drug or device by the U.S. Food and Drug Administration (FDA) under Chapter V (21 U.S.C. § 351 et seq.) of the Federal Food, Drug, and Cosmetic Act.

  • Antigen means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it.

  • Replacement Candidate means any Candidate Introduced by the Agency to the Client to fill the Engagement following the Introduction of another Candidate whose Engagement either did not commence or was terminated during the first 12 weeks of the Engagement;

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Licensed Compound means a TAK-385 Licensed Compound or a TAK-448 Licensed Compound.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • EBITDA Target means the Company's projected earnings before interest, taxes, one-time transition expenses, non-cash compensation expense charges, depreciation and amortization, as contained in the Company's budget for the Applicable Period and which is approved by the Board (without reference to any adjustments or revision, upwards or downwards, to such projected earnings which are subsequently approved by the Board as part of any subsequent revision to such budget), and (ii) the term "Financial Results" shall mean the Company's EBITDA calculated by reference to the Company's financial statements for the Applicable Period as filed with the Securities and Exchange Commission (the "SEC").

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • M2 Target Amount With respect to any Distribution Date, an amount equal to the lesser of (a) the product of (i) 87.00% and (ii) the Pool Balance for such Distribution Date and (b) the amount, if any, by which (i) the Pool Balance for such Distribution Date exceeds (ii) 0.50% of the Cut-off Date Balance.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].